Created at 3:33 p.m. Oct, 03, 2024
Author: mohannadkh10
Related Note: 1518966838874 1
Rationale for change

Step 1 15299
FA24 p447
Source: AMBOSS - https://next.amboss.com/us/article/4m03fg?q=palbociclib#Z23884df01bdf95903e74affa742d688c

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Empty field
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::^Other::^HighYield::4-LowerYield #AK_Step1_v12::#UWorld::Step::15299 #AK_Step1_v12::^Other::^EXPN::BGadd #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#OME_banner #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::SmallMoleculeInhibitors(TyrosineKinase_ProteasomeInhibitors_CDKInhibitors) !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#UWorld::COMLEX::26223 #AK_Step1_v12::^Other::^FA_Updates::FA2018 #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::08_Cancer_therapy-cell_cycle::*Palbociclib #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::10_Cell_Cycle_Dependent_Drug_Targets